易鑫(02858.HK)獲聯交所豁免嚴格遵守最低公眾持股量規定
易鑫集團(02858.HK)公布,緊隨要約截止後,待完成向聯席要約人轉讓彼等根據要約收購的相關要約股份後,公眾人士持有11.82億股公司股份,佔公司於要約截止公告日期的全部已發行股本約18.53%。根據聯交所就股份給予的豁免,公司所適用的最低公眾持股量為已發行股份的22.99%。因此公司最低公眾持股量規定未獲滿足。
於要約截止後,公司已向聯交所申請,於今年12月2日至明年4月1日止期間,臨時豁免嚴格遵守上市規則第8.08(1)(a)條的規定。於今年12月18日,聯交所已向公司授出臨時豁免,於豁免期內寬免嚴格遵守上市規則有關規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.